Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regulatory CD4+ T cells in pancreatic carcinoma

Thumbnail Image



Barilla, Rocky M
Diskin, Brian
Caso, Raul Caso
Lee, Ki Buom
Mohan, Navyatha
Buttar, Chandan
Adam, Salma
Sekendiz, Zennur
Wang, Junjie
Salas, Ruben D

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats


Citation Stats


<jats:title>Abstract</jats:title><jats:p>The drivers and the specification of CD4<jats:sup>+</jats:sup> T cell differentiation in the tumor microenvironment and their contributions to tumor immunity or tolerance are incompletely understood. Using models of pancreatic ductal adenocarcinoma (PDA), we show that a distinct subset of tumor-infiltrating dendritic cells (DC) promotes PDA growth by directing a unique T<jats:sub>H</jats:sub>-program. Specifically, CD11b<jats:sup>+</jats:sup>CD103<jats:sup>−</jats:sup> DC predominate in PDA, express high IL-23 and TGF-β, and induce FoxP3<jats:sup><jats:italic>neg</jats:italic></jats:sup> tumor-promoting IL-10<jats:sup>+</jats:sup>IL-17<jats:sup>+</jats:sup>IFNγ<jats:sup>+ </jats:sup>regulatory CD4<jats:sup>+</jats:sup> T cells. The balance between this distinctive T<jats:sub>H</jats:sub> program and canonical FoxP3<jats:sup>+ </jats:sup>T<jats:sub>REGS</jats:sub> is unaffected by pattern recognition receptor ligation and is modulated by DC expression of retinoic acid. This T<jats:sub>H</jats:sub>-signature is mimicked in human PDA where it is associated with immune-tolerance and diminished patient survival. Our data suggest that CD11b<jats:sup>+</jats:sup>CD103<jats:sup>−</jats:sup> DC promote CD4<jats:sup>+</jats:sup> T cell tolerance in PDA which may underscore its resistance to immunotherapy.</jats:p>


Journal article






Published Version (Please cite this version)


Publication Info

Barilla, Rocky M, Brian Diskin, Raul Caso Caso, Ki Buom Lee, Navyatha Mohan, Chandan Buttar, Salma Adam, Zennur Sekendiz, et al. (n.d.). Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regulatory CD4+ T cells in pancreatic carcinoma. Nature Communications, 10(1). 10.1038/s41467-019-09416-2 Retrieved from https://hdl.handle.net/10161/30185.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.